Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
As a cooperative, IPC is committed to the success of our members and offers select vendor partners exclusively to our GPO membership
choose a different site with more subcutaneous tissue
The full-length version of that molecule was the lead asset of RegeneRx Biopharmaceuticals, a publicly traded company that pushed thymosin beta-4 through multiple Phase 2 and Phase 3 trials for chronic wound healing, dry eye, and corneal injury under names like RGN-259, RGN-137, and RGN-352
CAGR 16.43% by value and 23.95% by volume through 2031 Novo Nordisk + Eli Lilly combined GLP-1 market share: 57.4% of total peptide therapy market in 2026 a duopoly of extraordinary concentration Oncology Peptide Therapy: 4.1% market share
Excess liver fat slows your metabolism and contributes to weight gain and metabolic diseases such as obesity and type 2 diabetes
US$ 21.48
US$ 20.01
US$ 20.55
US$ 22.47
US$ 20.65
US$ 20.85
US$ 21.90